Vortex Biosciences

About:

Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering.

Website: https://vortexbiosciences.com

Top Investors: EMV Capital, NetScientific PLC

Description:

Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering and informatics to deliver better tools for isolating and characterizing circulating tumor cells (CTCs). Vortex’s first product, the VTX-1 Liquid Biopsy System, automates the label free isolation and collection of viable CTCs directly from whole blood.

Total Funding Amount:

5.5M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)vortexbiosciences.com

Founders:

Dino Di Carlo, Elodie Sollier

Number of Employees:

11-50

Last Funding Date:

2023-06-22

IPO Status:

Private

Industries: